A 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride DMFs exist exist since differing nations have different regulations, such as 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride USDMF includes data on 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-[(2-Dimethylamino)ethoxy]-N-(3,5-trimethoxybenzoyl)benzylamine hydrochloride suppliers with USDMF on PharmaCompass.